2B70:XETRA:XETRA-iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (EUR)

ETF | Others |

Last Closing

USD 6.184

Change

+0.16 (+2.60)%

Market Cap

USD 0.52B

Volume

0.11M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-02 )

ETFs Containing 2B70:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.60% 88% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.60% 88% B+ 86% B+
Trailing 12 Months  
Capital Gain 5.62% 33% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.62% 32% F 37% F
Trailing 5 Years  
Capital Gain 30.03% 57% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 30.03% 52% F 55% F
Average Annual (5 Year Horizon)  
Capital Gain 5.30% 47% F 48% F
Dividend Return 5.30% 46% F 46% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.43% 46% F 56% F
Risk Adjusted Return 39.44% 39% F 44% F
Market Capitalization 0.52B 66% D+ 58% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.